Quantcast

Latest Sickle-cell disease Stories

2014-07-16 08:26:59

KINDU, Democratic Republic Of The Congo, July 16, 2014 /PRNewswire/ -- It is estimated that 25 percent of Congolese adults have sickle cell anemia trait, a debilitating disease of the blood transmitted genetically to newborn children. Of the 50,000 Congolese children born annually with sickle cell, 75 percent will die before age two. Support from the Gertler Family Foundation [http://www.gertlerfamilyfoundation.org ] (GFF) is saving the lives of hundreds of these children and...

2014-07-02 23:02:01

A potentially groundbreaking investigational drug designed to treat the painful vaso-occlusive crises that are the hallmark of sickle cell disease has been found to be safe following a clinical trial at UC Davis. Sacramento, CA (PRWEB) July 02, 2014 A potentially groundbreaking investigational drug designed to treat the painful vaso-occlusive crises that are the hallmark of sickle cell disease has been found to be safe following a clinical trial at UC Davis. Vaso-occlusive crises, during...

2014-07-02 12:51:45

NIH/National Institute of Diabetes and Digestive and Kidney Diseases Adults stop anti-rejection drugs after stem-cell transplant reverses sickle cell disease NIH trial success suggests a new treatment option for older, sicker patients Half of patients in a trial have safely stopped immunosuppressant medication following a modified blood stem-cell transplant for severe sickle cell disease, according to a study in the July 1 issue of the Journal of the American Medical Association. The...

2014-07-02 12:12:20

The JAMA Network Journals Use of a lower intensity bone marrow transplantation method showed promising results among 30 patients (16-65 years of age) with severe sickle cell disease, according to a study in the July 2 issue of JAMA. Myeloablative (use of high-dose chemotherapy or radiation) allogeneic hematopoietic stem cell transplantation (HSCT; receipt of hematopoietic stem cells "bone marrow" from another individual) is curative for children with severe sickle cell disease, but...

2014-06-19 08:29:56

SAN BRUNO, Calif., June 19, 2014 /PRNewswire-USNewswire/ -- June 19 is designated as World Sickle Cell Day. The international observance provides an opportunity to heighten awareness of the formidable public health challenge presented by the common, non-malignant blood disorder. http://photos.prnewswire.com/prnvar/20131216/DC33657LOGO-a Sickle cell disease is a genetic disorder in which the body produces abnormally shaped red blood cells. The sickled or c-shaped red blood cells can...

2014-06-16 08:28:24

Sub-study will investigate effects of MST-188 on tissue oxygenation in sickle cell disease patients experiencing a vaso-occlusive crisis SAN DIEGO, June 16, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that, in line with prior guidance, it has initiated patient enrollment in a sub-study within EPIC, its pivotal phase 3 study of MST-188 in sickle cell disease, to investigate and quantify the effect of MST-188 on tissue oxygenation, which will be...

2014-05-22 23:01:18

New St. Jude Children’s Research Hospital-led study reveals differences in the pneumococcal genome that explain why current vaccines aren’t better at protecting children with sickle cell disease from the bacterial infection. Memphis, Tenn. (PRWEB) May 22, 2014 Researchers have identified differences in the genetic code of pneumococcal bacteria that may explain why it poses such a risk to children with sickle cell disease and why current vaccines don’t provide better protection...

2014-05-22 16:26:56

Addresses critical unmet needs in blood banking and transfusion medicine - a fast, FDA-approved way to generate critical genetic matching information necessary to: NORCROSS, Ga., May 22, 2014 /PRNewswire/ -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, announced that the U.S. Food and Drug Administration (FDA) has granted approval for the company's PreciseType HEA test. The PreciseType HEA test is the first FDA-approved molecular assay designed...

2014-04-14 12:33:36

MST-188 decreased a marker of inflammation and red blood cell aggregation (50% reduction relative to control) SAN DIEGO, April 14, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that, in an ex vivo study conducted at Loyola University Medical Center, MST-188 reduced the mean erythrocyte sedimentation rate (ESR) by 50% relative to control in blood collected from individuals with sickle cell disease. ESR, a common laboratory test and measure of inflammation,...

2014-04-04 23:41:03

The campaign encourages donors and those affected by Sickle Cell to recruit six friends in their networks to help children afflicted with sickle cell. The Foundation urges interested parties to share information provided about sickle cell with six other people and to consider the impact they can have on the lives of chronically-ill children. Atlanta, GA (PRWEB) April 03, 2014 The Sickle Cell Foundation of Georgia, Inc. inspired by successful crowd funding campaigns in social media, has...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related